A multicenter, randomized, dose-finding study of gamma intracoronary radiation therapy to inhibit recurrent restenosis after stenting

Journal of Invasive Cardiology

Volumn 18, Issue 4, 2006, Pages 169-173

  Price, Matthew J ^a   Moses, Jeffrey W ^b   Leon, Martin B ^b   Mehran, Roxana ^b   Negoita, Manuela ^b   Lansky, Alexandra ^b   Collins, Michael ^b   Giap, Huan ^a   Lin, Ray ^a   Jani, Shirish ^a   Steuterman, Stephen ^a   Balter, Stephen ^b   Dalton, Jack ^c   Lipsztein, Roberto ^c   Tripuraneni, Prabhakar ^a   Teirstein, Paul S ^a  

^a SCRIPPS CLINIC   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c LENOX HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; IRIDIUM 192; METAL;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DOSIMETRY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; FOLLOW UP; GAMMA INTRACORONARY RADIATION THERAPY; GAMMA IRRADIATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOMES RESEARCH; RADIATION DOSE; RADIATION SAFETY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RESTENOSIS; REVASCULARIZATION; RISK REDUCTION; THROMBOSIS; TREATMENT FAILURE; CORONARY BLOOD VESSEL; GAMMA RADIATION; MIDDLE AGED; RADIATION EXPOSURE; RADIATION RESPONSE; STENT; TREATMENT OUTCOME;

AGED; CORONARY RESTENOSIS; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GAMMA RAYS; HUMANS; MALE; METALS; MIDDLE AGED; STENTS; TREATMENT OUTCOME;

EID: 33745077726     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Teirstein PS, Massullo V, Jani S, et al. N Engl J Med 1997;336:1697-1703.
2. Waksman R, White RL, Chan RC, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-2171.
3. Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-256.
4. Gillette EL, Powers BE, McChesney SL, et al. Response of aorta and branch arteries to experimental intraoperative irradiation. Int J Radiat Oncol Biol Phys 1989;17:1247-1255.
5. Giap H, Massullo V, Teirstein PS, Tripuraneni P. Theoretical assessment of late cardiac complications from endovascular brachytherapy for restenosis prevention. Cardiovasc Radiat Med 1999;1:233-238.
6. Wong SC, Teirstein PS, Moses JW. Nine-month clinical outcomes after intravascular radiation therapy for in-stent restenosis: A report from the GAMMA-II registry. Am J Cardiol 2000;86:8A.
7. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol 1999;10:499-506.
8. Meyer JL. The radiation therapy of benign diseases: Current indications and techniques. In: Front Radiat Ther Oncol Basel: Karger, 2001.
9. Waksman R, Cheneau E, Ajani AE, et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: Results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation 2003;107:1744-1749.
10. Waksman R, Ajani AE, White RL, et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with instent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 2001;103:2332-2335.
11. Waksman R, Ajani AE, White RL, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 2004;109:340-344.
12. Leon MB, Teirstein PS, Moses JW, et al. Declining long-term efficacy of vascular brachytherapy for in-stent restenosis: 5-year follow-up from the GAMMA I Randomized Trial (AHA Abstr). Circulation (Supplement) 2004.
13. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
14. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
15. Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-27.
16. Tanabe K, Serruys PW, Grube E, et al. TAXUS III Trial: In-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003;107:559-564.
17. Degertekin M, Regar E, Tanabe K, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: The first clinical experience. J Am Coll Cardiol 2003;41:184-189.
18. Orlic D, Bonizzoni E, Stankovic G, et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: Immediate and mid-term results. J Am Coll Cardiol 2004;43:1154-1160.
19. Briguori C, Colombo A, Airoldi F, et al. Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease. Am Heart J 2005;150:807-813.
20. Ortolani P, Marzocchi A, Aquilina M, et al. 32P brachytherapy in the treatment of complex Cypher in-stent restenosis. J Intervent Cardiol 2005;18:205-211.